Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain - SMTP

http://tinyurl.com/a22xulc - Zogenix (ZGNX): FDA Advisory Committee to Review Chronic Pain Treatment ...

Zohydro ER is Zogenix's lead investigational product candidate for the management of moderate-to-severe chronic pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. "If approved, Zohydro ER could be the ...

The Great Opioid Debate: PROP vs. PROMPT

That question is at the heart of a controversy that has boiled over since July when 37 physicians in pain management, public health, psychiatry and other specialties issued a citizen petition calling on the FDA to require opioid label changes that ...

Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain

SAN DIEGO Zogenix, Inc. , a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced that the U.S. Food and Drug ...